LMU University Hospital Munich: Real-time Data Visualization and Analysis in Clinical Ttrials with Imaging Endpoints

“mint Analytics expands your means of structured response assessment in mint Lesion™ by instantaneous visualization of the collected data, as a whole or per individual trial,” states PD Dr. Wolfgang Kunz, Head of Oncological Imaging and of the Oncological Study Center at the Ludwig-Maximilians-University Hospital Munich.

PD Dr. Kunz recounts how he and his team are able to keep a detailed overview of the status of their clinical trials and describes how sponsors and imaging CROs can benefit from mint Lesion™ and its add-on mint Analytics.

Read the Success Story here.

Clinical Trials Trial Monitoring Data Collection Data Analysis Clinical Trial Center mint Analytics

Related Resources

Related Resources

Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy

University Hospital Munich (LMU): Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy

A recent study[1] conducted by researchers at the University Hospital Munich (LMU) investigated the role of tumor growth rate (TGR) in predicting the…

Advancing Neuro-Oncology Assessments: Mint Medical to Integrate Newly Published RANO 2.0 Criteria into mint Lesion™

Glioblastomas and other gliomas are the most common malignant primary brain tumor types, yet few effective therapies are available. Clinical research…

Study Highlights the Potential of Radiomics in Medical Intervention

A recent study conducted by the Medical University of Innsbruck highlights the potential of radiomics in exploring the impacts of Radiochemotherapy…